Viewing Study NCT02501603


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2025-12-30 @ 8:25 PM
Study NCT ID: NCT02501603
Status: COMPLETED
Last Update Posted: 2023-01-27
First Post: 2015-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer
Sponsor: Yonsei University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module